Investment Backing The merger with an affiliate of Perceptive Advisors and ongoing funding create a stronger capital runway to accelerate sales expansion, product development, and customer onboarding across hospital networks.

ED ICU Focus Vapotherm's Precision Flow high velocity therapy targets emergency department and ICU patients with heated humidified high flow, including mask-free options, offering a differentiated respiratory support solution for critical care teams.

IDN Growth With revenue in the mid-range and a 201-500 employee base, Vapotherm is well positioned to pursue multi-site contracts within Integrated Delivery Networks and regional health systems for broad adoption of its high-flow therapy platform.

Ecosystem Partnerships The company’s merger and investor engagement open opportunities for channel partners, distributors, and hospital purchasing groups to scale reach, deployment, training, and after-sales service.

Value Proposition Vapotherm’s technology delivers oxygenation and high-flow respiratory support that can enhance patient comfort in hospital settings, providing a clear value proposition for clinicians and procurement teams focused on improving respiratory care outcomes.